Sohini Das And Ruchika Chitravanshi

Stories by Sohini Das And Ruchika Chitravanshi

Luxury Cars, Bikes Rev Up For Festival Season

Luxury Cars, Bikes Rev Up For Festival Season

Rediff.com   23 Sep 2025

Luxury carmakers are shifting into high gear with a mix of product launches, personalised experiences and lifestyle-led engagement.

Patients to benefit from GST cut, but pharma firms may face margin pressure

Patients to benefit from GST cut, but pharma firms may face margin pressure

Rediff.com   12 Sep 2025

The rationalisation of goods and services tax (GST), announced on Wednesday, directly lowers the cost of everyday medical consumables, and also high-end therapies in oncology and rare diseases, helping reduce out-of-pocket patient expenditure and better adherence to medication.

Helped by GST move, PV sales growth may rebound to 7% by FY27: Maruti

Helped by GST move, PV sales growth may rebound to 7% by FY27: Maruti

Rediff.com   12 Sep 2025

The country's largest carmaker Maruti Suzuki India expects auto sales to bounce back to the glory days of 7 per cent growth by FY 27, helped by the proposed GST rate cut which is expected to bring down car prices by 3.5 to 8.5 per cent.

Rare Earth Magnet Crunch Persists For Automakers

Rare Earth Magnet Crunch Persists For Automakers

Rediff.com   11 Sep 2025

'Despite assurance from China, none of the companies have received supplies from Chinese sellers.'

How India's pharma cos plan to tackle steep US tariffs

How India's pharma cos plan to tackle steep US tariffs

Rediff.com   10 Sep 2025

As the potential threat of a steep 200 per cent tariff on pharmaceutical imports hangs in the air, analysts and industry insiders feel that focus on exports to non-US regions as well as domestic market will increase as a long-term trend. US President Donald Trump told CNBC's Squawk Box in the first week of August that planned tariffs on import of pharmaceutical products to the US could eventually reach up to 250 per cent.

Impact of 50% US tariff would be concentrated in Q2: CEA Nageswaran

Impact of 50% US tariff would be concentrated in Q2: CEA Nageswaran

Rediff.com   30 Aug 2025

The 50 per cent US tariff on Indian goods pose a downside risk to growth but the impact is expected to be short-lived for the economy, and consumption demand could see an uptick after the new goods and service tax (GST) rates are implemented which could even offset the external uncertainty, Chief Economic Advisor (CEA) V Anantha Nageswaran reckoned on Friday.

FinMin: 'Setbacks Make Us Stronger'

FinMin: 'Setbacks Make Us Stronger'

Rediff.com   28 Aug 2025

'If the near-term economic pain is absorbed more by those who have the ability and the financial strength to do so, then small and medium enterprises in downstream industries will emerge stronger from the trade imbroglio.'

'Bureaucrats Resist Meeting Public...'

'Bureaucrats Resist Meeting Public...'

Rediff.com   25 Aug 2025

'...as then it brings them closer to the complaints and grievances that the public faces.'

25% Donald Trump tariff likely to weigh on pharma margins: Analysts

25% Donald Trump tariff likely to weigh on pharma margins: Analysts

Rediff.com   12 Aug 2025

If pharmaceutical exports from India to the US come under a 25 per cent tariff bracket, the impact on earnings before interest, tax, depreciation and amortisation (Ebitda) could be around 5 per cent, felt analysts. This is after assuming that about 75 per cent of the tariff would be passed on.

US tariff impact: India's FY26 GDP growth likely to take 60-bp hit

US tariff impact: India's FY26 GDP growth likely to take 60-bp hit

Rediff.com   8 Aug 2025

The US' move to raise the tariff on most Indian goods to 50 per cent could drag India's GDP growth for FY26 by 35 to 60 basis points, according to various economists. One basis point (bp) is equal to 0.01 per cent.

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Rediff.com   31 Jul 2025

India's pharmaceuticals and medical devices industries are still hopeful that trade negotiations with the US could cut a fairer deal for both sides, after President Donald Trump announced a 25 per cent tariff rate on India on a social networking platform without divulging the finer details.

P&G's New Boss Is Big Into Bollywood Movies

P&G's New Boss Is Big Into Bollywood Movies

Rediff.com   30 Jul 2025

Shailesh Jejurikar has 'always made an effort to stay close to his roots.'

There is more room for monetary policy easing, says Finance Ministry

There is more room for monetary policy easing, says Finance Ministry

Rediff.com   29 Jul 2025

With inflation comfortably below the Reserve Bank of India's (RBI's) 4 per cent median target and likely to undershoot its 3.7 per cent projection for 2025-26 (FY26), there is room for the monetary policy easing cycle to be sustained, the Finance Ministry said on Monday. The comments, featured in the ministry's Monthly Economic Review for June 2025, assume significance ahead of the Monetary Policy Committee (MPC) meeting of the Reserve Bank of India (RBI) scheduled to begin from August 5.

Tesla Hits Indian Roads But Misses Mass Appeal

Tesla Hits Indian Roads But Misses Mass Appeal

Rediff.com   29 Jul 2025

Analysts believe Tesla will first focus on building the Model Y brand before expanding -- both in terms of volume and models.

Govt to Monitor Non-Essential Drug Prices

Govt to Monitor Non-Essential Drug Prices

Rediff.com   28 Jul 2025

The National Pharmaceutical Pricing Authority will monitor how companies are increasing prices of non-scheduled drugs.

Coerced into signing documents: Sunjay Kapur's mother

Coerced into signing documents: Sunjay Kapur's mother

Rediff.com   26 Jul 2025

In her letter to the Sona BLW board, Rani Kapur said documents executed by her at a time of "mental and emotional vulnerability" were being misused.

'People Ask Why You Have To Be So Rigid'

'People Ask Why You Have To Be So Rigid'

Rediff.com   17 Jul 2025

'It is not rigidity.' 'I am just sticking to what I believe very strongly in, particularly if you have been given an opportunity to serve the country....'

High equality ranking for India masks deeper gaps, say economists

High equality ranking for India masks deeper gaps, say economists

Rediff.com   14 Jul 2025

A recent World Bank report placing India among the most equal countries globally may present a limited view of inequality, with economists suggesting that broader data sets could tell a different story. According to the report, India's Gini index (or coefficient/ratio), a key measure of inequality, stood at 25.5 in 2022-23, placing the country fourth globally in terms of equality, behind only the Slovak Republic, Slovenia, and Belarus.

EV Sales Surge on Back of Government Push; Hybrids Lag

EV Sales Surge on Back of Government Push; Hybrids Lag

Rediff.com   8 Jul 2025

Despite the benefits of hybrid technology, a lack of government backing and few launches have kept the segment from gaining ground.

Breaking up bad assets: Can IBBI's part-resolution rewire insolvency rules?

Breaking up bad assets: Can IBBI's part-resolution rewire insolvency rules?

Rediff.com   7 Jul 2025

The recent notification by the Insolvency and Bankruptcy Board of India (IBBI) allowing part-resolution of stressed assets of companies under the insolvency process has sent many resolution professionals (RPs) and committees of creditors (CoCs) back to the drawing board to reassess their strategies for resolving corporate insolvencies.